The CSE was proud to welcome IM Cannabis Corp (CSE:IMCC) to open the market at the CSE Media Centre on October 17, 2019.

IM Cannabis is a leading medical cannabis provider. Since 2010, the company has offered a full spectrum of government-licensed cannabis products, from generic to GMP-certified and pharmaceutical-grade, for both wholesale and retail clients. IM Cannabis is an industrial innovator, constantly moving forward in the rapidly developing medical cannabis market and closely collaborating with research institutions and start-up companies.

“We are enormously proud to open the market at the CSE. We’ve waited a long time for that. The team came from Israel and everybody is very excited,” remarked CEO Oren Shuster.

“IMC started in 2010 in Israel as one of the first medical cannabis companies in the world. What we have done, we have taken our know-how and expertise to Europe, and now we’re working in Europe, and we’re a pure European player. The main market that we are going to is Germany, and we will start to have substantial sales early next year. We have a very good focus for next year, and I think the fact that we are coming with the backing of clinical trials, and a lot of research done in Israel and bringing it into the EU market makes us different.”

A number of prominent members of the IM Cannabis team joined Shuster at the Market Open, including Co-Founder Rafael Gabay, COO Amir Goldstein, CFO Shai Shemesh, and more.

View the podcast for this Market Open featuring Oren Shuster here.

For more details about the CSE Media Centre, including information on upcoming Market Opens, please visit the CSE website, or follow us on social media.